| Revenue | SEK 4,2M | -6% |
| EBITDA | SEK -336K | +73% |
| Net profit | SEK 147K | +112% |
| Total assets | SEK 3,1M | -9% |
| Equity | SEK 822K | +22% |
| Employees | — | — |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 6 368 | 8 030 | 7 358 | 4 512 | 4 234 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −315 | 1 077 | 429 | −1 264 | −336 |
| Depreciation & amort. | −153 | −78 | −87 | −98 | −98 |
| EBIT | −468 | 999 | 342 | −1 362 | −434 |
| Net financials | −8 | −1 | −1 | 1 | 581 |
| Profit before tax | −476 | 914 | 341 | −1 277 | 147 |
| Tax | −0 | −55 | −92 | −0 | −0 |
| Net profit | −476 | 859 | 249 | −1 277 | 147 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 846 | 6 046 | 5 605 | 3 372 | 3 071 |
| Equity | 844 | 1 702 | 1 952 | 675 | 822 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2 692 | 3 944 | 3 158 | 2 197 | 2 248 |
| Total debt | 2 692 | 3 944 | 3 158 | 2 197 | 2 248 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
NG Chief Executive Officer | Chief Executive Officer | 2021 |
PA Audit | Audit | 2025 |
| Former (2) | ||
LJ | Audit | 2021 – 2022 |
LD | Audit | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2021 | |
No shareholder data available.
| Person | Role here | Other companies |
|---|---|---|
| Leif Johan Christer Lüsch | Audit | 0 companies |
| Nursen Gündüz | Chief Executive Officer | 0 companies |
| Pekka Anderman | Audit | 0 companies |
| Lars Daniel Andreas Boström | Audit | 0 companies |
| Helen Rebecka Gündüz | Deputy Board Member | 0 companies |